IRF7 activated a positive feedback regulatory loop of interferon signaling and subsequently activated the RIG-I-like receptor signaling pathway and BCL-2 expression to inhibit apoptosis and promote proliferation, invasion and migration of non-small cell lung cancer cells. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.